Share this NATF page   

July President's Letter

Dr. Goldhaber

I’ve just returned from the once-every-2-years International Society of Thrombosis and Haemostasis (ISTH) Scientific Symposium. We convened in Toronto... (read more)

Thrombosis in the News


(Pictured: Jerome Kersey, former NBA player)

Two NBA Star Athletes Suffer from Blood Clots in just Two Days

This week has been particularly scary as two NBA stars are suspected to have suffered from pulmonary embolisms within a day of each other.  A pulmonary embolism is a blood clot that travels from the lower extremities and lands in the lungs.

Jerome Kersey, former member of the Portland Trail Blazers basketball team, passed away due to a pulmonary embolism...


(Pictured: Brian Vickers, NASCAR driver)

NASCAR Driver Brian Vickers Experiencing Recurrent Blood Clots

NASCAR driver Brian Vickers will be missing the Sprint Cup Series race as a result of his ongoing struggle with recurrent blood clots.  He had been scheduled to race this upcoming weekend, but suddenly began experiencing symptoms of blood clots on Thursday evening...

Thrombosis Education


2015 Thrombosis Summit
Saturday, September 26

7:30 AM - 12:00 PM
Fairmont Copley Plaza Hotel, Boston

The 2015 Thrombosis Summit provides the latest innovations in testing, diagnosis, and treatment of thrombotic disorders.  Sessions are led by national and local experts, who provide in-depth guidance on acute coronary syndromes, stroke in atrial fibrillation, and venous thromboembolism, as well as incorporating these cutting-edge techniques into practice.

Healthcare providers can earn up to 3.5 CME credits for attendance at the program. More information

Register Here

Treatment Options for DVT/PE Patients

How do healthcare providers decide which treatments are the best option for their patients?  Read this article to find out more about DVT/PE treatment goals, options, risks, and decision-making. 


Anticoagulant Comparison Chart

Which anticoagulant is right for me?

For many years, Warfarin was the only oral anticoagulant commonly used to treat blood clots. In the past five years, the FDA has approved four new oral anticoagulants for the treatment of DVT, PE, and SPAF. Find out the differences between the five FDA-approved oral anticoagulants by viewing the chart.

Articles and Updates


Announcing NATF's 10th Anniversary Signature Event

NATF's next Signature Event has been rescheduled to coincide with our 10th anniversary, and will take place on Thursday, March 10, 2016 at the Mandarin Oriental Hotel in Boston. Please mark your calendars for this special event!  



AC Forum Anticoagulation Boot Camp

Join the Anticoagulation Forum for their 3rd Anticoagulation Boot Camp, July 23rd and 24th, 2015 in Boston.  This compact 2-day conference offers comprehensive learning for those new to anticoagulation or a refresher on updates on the changing practice of anticoagulation.

Expert faculty will provide an interactive setting in a small group learning model with plenty of time for Q&A and dynamic discussion.  Nursing and pharmacy CE credits will be provided.

Prior programs have sold out so register soon to secure your spot.  

Visit for more infomation or to register.




About NATF





Giving to NATF

North American Thrombosis Forum
368 Boylston Street
Brookline, MA 02445

617 - 730 - 4120

NATF is a 501(c) nonprofit

Contact Us

© 2012 North American Thrombosis Forum

Web Development by MTC